ポスト

NEW SERIES on #pregnancy in rheumatic disease calls for a reconsideration of therapeutic decisions to optimise the safe and effective use of DMARDs, and proposes solutions to the challenges of studies in pregnancy https://t.co/sNTtr1C6Oo #EULAR2024 https://t.co/Uchrtqg66P

メニューを開く

The Lancet Rheumatology@TheLancetRheum

人気ポスト

もっと見る
Yahoo!リアルタイム検索アプリ